Novartis’ Alcon unit is picking up 2016 Fierce 15 company PowerVision in a $285 million deal for its flexible, fluid-based intraocular lens.
Canvassing more than 400,000 people in 8 months, Apple has finished an investigation of its smartwatch’s ability to detect irregular heart rhythms.
The FDA will evaluate the state of the science around medical device materials, with subsets of patients developing painful responses to implants.
Stryker has acquired OrthoSpace, developers of a therapy for severely torn rotator cuffs, in a deal worth up to $220 million.
Ortho received a CE mark for its new multitest platform that allows laboratories to run two in vitro diagnostic tests simultaneously on one slide.
Cala Health launched a collaboration with Massachusetts General Hospital to build out its noninvasive nerve stimulation platform.
FundamentalVR has added haptic glove compatibility to its VR surgeon training system so they can feel the shape and weight of simulated 3D objects.
Smith & Nephew plans to absorb regenerative medicine player Osiris Therapeutics in a $660 million deal to expand its wound care business.
Short seller Kerrisdale Capital launched an attack on iRhythm, makers of the Zio heart monitor patch, describing a looming reimbursement crisis.
OnMed's self-contained medical unit allows physicians to remotely take vital signs and diagnose conditions, and has its own robotic minipharmacy.
